Ceva Animal Health (an ARCHIMED company) and Mitsui & Co. announce the creation of Ceva Bussan Animal Health, a Joint Venture in the Japanese animal health market.

ARCHIMED takes another step in its long-term commitment to Japan, welcoming four of Japan's leading scientists to bring sector depth and network to its investment activities.

Representatives of ARCHIMED joined the Clubhouse Mini Forum at Meiji Gakuin University in Tokyo, reaffirming their support for the community.

EURÊKA mentors meet supported PhD researchers at the University of Tokyo, providing strategic guidance and strengthening international collaboration to advance science in areas of high unmet medical need.

Naobios (Clean Biologics group, an ARCHIMED company) and Tokyo Metropolitan Institute of Medical Science partner to develop a new live-attenuated vaccine against mpox.

Tokyo-listed global developer and distributor of medical electronic equipment, Nihon Kohden, partners with ARCHIMED to pursue Ad-Tech’s growth.

ARCHIMED initiates the delisting from the Korea Exchange of Jeisys Medical, a leading developer of aesthetic medicine devices.